These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9309459)

  • 1. Estimated prevalence of undiagnosed glucose intolerance from hyperandrogenic anovulation among women requesting electrolysis.
    Dumesic DA; Herrmann RR; O'Brien AM
    Int J Fertil Womens Med; 1997; 42(4):255-60. PubMed ID: 9309459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
    Ansarin H; Aziz-Jalali MH; Rasi A; Soltani-Arabshahi R
    Arch Iran Med; 2007 Jan; 10(1):7-13. PubMed ID: 17198446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What every physician should know about polycystic ovary syndrome.
    Rosenfield RL
    Dermatol Ther; 2008; 21(5):354-61. PubMed ID: 18844713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome.
    Goudas VT; Dumesic DA
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of androgen excess among patients with minimal unwanted hair growth.
    Souter I; Sanchez LA; Perez M; Bartolucci AA; Azziz R
    Am J Obstet Gynecol; 2004 Dec; 191(6):1914-20. PubMed ID: 15592272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian women.
    Davis SR; Knight S; White V; Claridge C; Davis BJ; Bell R
    Gynecol Endocrinol; 2002 Dec; 16(6):443-6. PubMed ID: 12626030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes and polycystic ovary syndrome.
    Legro RS
    Fertil Steril; 2006 Jul; 86 Suppl 1():S16-7. PubMed ID: 16798276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hirsutism].
    van Zuuren EJ; Pijl H
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group.
    Farah L; Lazenby AJ; Boots LR; Azziz R
    J Reprod Med; 1999 Oct; 44(10):870-4. PubMed ID: 10554748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.
    Escobar-Morreale HF; Roldán B; Barrio R; Alonso M; Sancho J; de la Calle H; García-Robles R
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4182-7. PubMed ID: 11095451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
    Szpringer EA; Lutnicki KR; Zych IS
    Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Androgen Excess in Women: Accuracy of Self-Reported Excess Body Hair Growth and Menstrual Dysfunction.
    Chan JL; Pall M; Ezeh U; Mathur R; Pisarska MD; Azziz R
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3688-95. PubMed ID: 32442282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.